Bristol Scientists Discover New Molecule That Could Prevent Tumour GrowthJuly 12, 2002Scientists at Bristol University have discovered a new molecule that could prevent tumour growth. Dr Dave Bates and Dr Steve Harper in the Microvascular Research Laboratories in the Department of Physiology, working in collaboration with clinicians at Southmead Hospital, have discovered a type of vascular endothelial growth factor (VEGF) found in normal kidneys that has a different structure from that found in kidney cancer. The research findings will be published in the world`s most prestigious scientific cancer journal, `Cancer Research`, next week [15 July 2002]. This new form of VEGF, VEGF165b, has a different structure at the end of the molecule and is switched off in kidney cancer. It also seems to be able to inhibit at least three of the actions of VEGF on blood vessels: cell division, cell migration and the ability of blood vessels to widen. The discovery of this new form of VEGF means that it could be possible to prevent tumour growth by starving the tumour using the body`s own anti-cancer agent, VEGF165b. The advantage of using VEGF165b over established compounds to treat cancer is that VEGF165b is a natural molecule produced by the body under normal circumstances. Other chemical or antibody-based treatment to inhibit tumour vessel growth are all foreign proteins or molecules with unpredictable side effects. The growth of any cancer depends on its ability to maintain a blood supply that will deliver nutrients. For a cancer to grow from the size of a pinhead to that of a golf-ball, the blood supply of the tumour has to grow with the expansion of the tumour itself. If the tumour outgrows its own blood supply, parts of it will begin to die. Many new cancer therapies are based on starving the tumour of nutrients by attacking the tumour blood supply rather than the cancer cells. New blood vessel growth is also necessary for many normal body functions. These include the development of the embryo and, in adults, wound healing, the development of the placenta in pregnancy and of muscles during physical training programmes. However, it is thought that adults can live healthily without blood vessel growth for extended periods of time. This blood vessel growth is controlled by many factors, the most powerful of which is the protein, vascular endothelial growth factor. Dr Bates and Dr Harper, said: "We are very excited by our discovery. The next aim of the research group is to determine if, and how, this new molecule might be useful as a treatment for cancer, vascular disease, arthritis and other diseases." | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. International study supports new standard of treatment for women with advanced ovarian cancer Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Plants display 'molecular amnesia' Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Dancing atoms now understood In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||